Go-to-Market Strategy for a UK based Diagnostics Company
|
|
A UK based diagnostics company providing Fluorescence in situ hybridization (FISH) based rapid tests has plans to enter the Indian market. Read more to know how we supported them in designing a Go-to-Market strategy by conducting a detailed market assessment.
|
0 Comments
Quantitative Brand Name Testing for a Global Medical Device Company
(Focus: APAC)
Our client needs support in finalizing on a brand name that would best represent their portfolio of companion diagnostics services. Read more to know how we used quantitative brand name testing exercise to support the client.
Customer Satisfaction Research (NPS) for an Australian Medical Device CRO
(Focus: Australia)
Our client, a mid-sized, Australia CRO, offering niche services to the medical device industry, has plans to further expand its site network and needed supported in tracking their customer satisfaction. Read more to understand how we helped the client with the NPS study in Australia
Promotional Messaging Support for a Scandinavian Medical Device Company
(Focus: APAC)
A Scandinavian medical device company entering the APAC market, needed support in choosing the content for promotional messaging, for its newly launched Point of Care (PoC) device. Read more to know how we helped our client with this problem.
Conference Impact Assessment of Global Medical Device Company
(Focus: APAC)
Background: Our US-based client, with a portfolio of cardiology/oncology interventional medical devices, planned to understand brand awareness among customers by hosting a conference.
Key Stakeholder Engagement Strategy for a Point of Care Device Company
(Focus: APAC)
Background: A leading medical device company is planning to launch a Point of Care (PoC) device for detecting infectious disease in Singapore. The company is looking for support with the key clinical stakeholder engagement strategy for their sales team.
Market Access Strategy for an AI-Powered Device (Focus: India)
Authors: A. Shukla, R.M. Dokala, J.R. Philomen
The Client
Our EU-based client is developing an AI-driven device for the diagnosis of a common diabetes-related condition. They intend to launch the device in India, which has the second highest diabetic population in the world.
The Business Problem
The client sought our help to devise a market access strategy to ensure the device’s integration into routine clinical practice upon its launch. They specifically wanted to know which pricing strategy to adopt considering the price-sensitive nature of the Indian market.